Tampering of opioid analgesics: a serious challenge for public health?

Addiction

National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Published: October 2016

Download full-text PDF

Source
http://dx.doi.org/10.1111/add.13436DOI Listing

Publication Analysis

Top Keywords

tampering opioid
4
opioid analgesics
4
analgesics serious
4
serious challenge
4
challenge public
4
public health?
4
tampering
1
analgesics
1
serious
1
challenge
1

Similar Publications

Purpose: To assess whether exposure to an extended-release (ER) oxycodone with abuse deterrent properties (ADF) reduced tampering of oxycodone in a real-world, postmarket setting to address the thinking behind Category 4 labeling by the FDA.

Methods: Data from an observational cross-sectional study of the general adult population (2022) was used under a causal framework to estimate the confounding-adjusted odds of tampering oxycodone after exposure to two types of ADF ER oxycodone. The tampering behaviors of those who used only single entity immediate-release (SE-IR) oxycodone was used as a comparison.

View Article and Find Full Text PDF

ASOS, a national monitoring study to assess narcotic prescriptions and indications in France since 2001.

Therapie

October 2024

Centre d'Évaluation et d'Information sur la Pharmacodépendance - Addictovigilance, Service de pharmacologie médicale, CHU de Bordeaux, 33000 Bordeaux, France; Université de Bordeaux, Inserm, Bordeaux Population Health Research Centre, Team, Pharmacoepidemiology, UMR 1219, 33000 Bordeaux, France. Electronic address:

Introduction: Analgesics are among the most widely used drugs worldwide. The French Addictovigilance Network (FAN) established the antalgiques stupéfiants et ordonnances sécurisées (ASOS [narcotic analgesics and secure prescriptions]) survey in order to assess the dissemination of tamper-resistant prescription forms for narcotic analgesic within the medical community, as well as the nature and evolution of the prescriptions. After outlining the missions of the FAN, this article will describe the population treated with narcotic analgesics in France, their therapeutic indications and how the data have evolved since 2007.

View Article and Find Full Text PDF

Introduction: In this perspective review, we evaluated the clinical management of fatal fentanyl overdose in several routes of administration, concentrating on both legally prescribed and illegally produced formulations.

Methods: A literature search was conducted on Web of Science, PubMed, and Google Scholar databases, using the following keywords: fentanyl, illicit fentanyl, deaths, misuse, abuse, and naloxone. We included only articles whose abstracts were available in English.

View Article and Find Full Text PDF

Review of Opioid Abuse-Deterrent Formulations: Impact and Barriers to Access.

J Pain Res

June 2024

Department of Anesthesiology and Pain Management, University of Miami, Miller School of Medicine, Miami, FL, USA.

The misuse and abuse of opioid analgesics continue to pose a serious public health concern, but for some patients, opioids remain an important analgesic option. Extended-release (ER) opioid formulations are effective for treating chronic pain and are supported by multiple 12-week efficacy studies. ER opioids often contain a high opioid content, and similar to immediate-release (IR) formulations, are subject to abuse, misuse, and diversion.

View Article and Find Full Text PDF

Opioid tampering and diversion pose a serious problem for hospital patients with potentially life-threatening consequences. The ongoing opioid crisis has resulted in medications used for pain management and anesthesia, such as fentanyl and morphine, being stolen, substituted with a different substance, and abused. This work aims to mitigate tampering and diversion through analytical verification of the administered drug before it enters the patient.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!